Does Pre-Operative Tranexamic Acid Increase the Incidence of Thromboembolism in Primary Lower Limb Arthroplasty?

Veenesh Selvaratnam, James R. Fountain, Nigel J. Donnachie, Thomas G. Thomas, Fintan A. Carroll

Wirral University Teaching Hospital NHS Foundation Trust, Wirral, UK.
Wirral University Teaching Hospital NHS Foundation Trust, Wirral, UK..

DOI: 10.4236/ojo.2013.36046                

Abstract

Introduction: Tranexamic Acid (TA) has been shown to decrease peri-operative bleeding in primary lower limb arthroplasty surgery. There are still concerns with regards to the increased risk of thromboembolic events with the use of TA. The aim of this study was to assess whether the use of pre-operative TA increased the incidence of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in Total Hip Replacement (THR) and Total Knee Replacement (TKR). Methods: Patients who underwent primary THR or TKR between August 2007 and August 2009 were identified from the databases of three surgeons within the lower limb arthroplasty unit. A retrospective case notes analysis was performed. DVT was diagnosed on Duplex Ultrasound Scan and PE on CT Pulmonary Angiogram. A positive result was a diagnosis of DVT or PE within 3 months of surgery. Results: 701 patients underwent primary THR and TKR over the 2-year period. 320 patients (189 THR, 131 TKR) received TA pre-operatively. 381 patients (190 THR, 191 TKR) did not receive TA prior to surgery. A total of 8 (2.5%) patients who received TA were diagnosed with either a DVT (4) or PE (4) post operatively. In those patients not receiving TA, 6 had a DVT and 4 had a PE, a total of 10 (2.6%). Conclusion: Pre-operative use of Tranexamic Acid in primary THR and TKR does not increase the incidence of DVT and PE.

Keywords

Tranexamic Acid; DVT; PE; TKR; THR

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	I. M. Nilsson, “Clinical Pharmacology of Aminocaproic and Tranexamic Acids,” Journal of Clinical Pathology, Vol. 14, No. 33, 1980, pp. 41-47.
[2]	G. Benoni and H. Fredin, “Fibrinolytic Inhibition with Tranexamic Acid Reduces Blood Loss and Blood Transfusion after Knee Arthroplasty: A Prospective, Randomised, Double-Blind Study of 86 Patients,” The Journal of Bone & Joint Surgery, Vol. 78, No. 3, 1996, pp. 434-440.
[3]	K. M. Ho and H. Ismail, “Use of Intravenous Tranexamic Acid to Reduce Allogeneic Blood Transfusion in Total Hip and Knee Arthroplasty: A Meta-Analysis,” Anaesthesia and Intensive Care, Vol. 31, No. 5, 2003, pp. 529-537.
[4]	G. Benoni, S. Lethagen and H. Fredin, “The Effect of Tranexamic Acid on Local and Plasma Fibrinolysis during Total Knee Arthroplasty,” Thrombosis Research, Vol. 85, No. 3, 1997, pp. 195-206. http://dx.doi.org/10.1016/S0049-3848(97)00004-2
[5]	M. A. Camarasa, G. Olle, M. Serra-Prat, et al., “Efficacy of Aminocaproic, Tranexamic Acids in the Control of Bleeding during Total Knee Replacement: A Randomized Clinical Trial,” British Journal of Anaesthesia, Vol. 96, No. 5, 2006, pp. 576-582. http://dx.doi.org/10.1093/bja/ael057
[6]	J. C. Alvarez, F. X. Santiveri, I. Ramos, E. Vela, L. Puig and F. Escolano, “Tranexamic Acid Reduces Blood Transfusion in Total Knee Arthroplasty Even When a Blood Conservation Program Is Applied,” Transfusion, Vol. 48, No. 3, 2008, pp. 519-525. http://dx.doi.org/10.1111/j.1537-2995.2007.01564.x
[7]	N. M. Orpen, C. Little, G. Walker and E. J. Crawfurd, “Tranexamic Acid Reduces Early Post-Operative Blood Loss after Total Knee Arthroplasty: A Prospective Randomised Controlled Trial of 29 Patients,” The Knee, Vol. 13, No. 2, 2006, pp. 106-110. http://dx.doi.org/10.1016/j.knee.2005.11.001
[8]	F. E. Ralley, D. Berta, V. Binns, J. Howard and D. D. Naudie, “One Intraoperative Dose of Tranexamic Acid for Patients Having Primary Hip or Knee Arthroplasty,” Clinical Orthopaedics and Related Research, Vol. 468, No. 7, 2010, pp. 1905-1911. http://dx.doi.org/10.1007/s11999-009-1217-8
[9]	M. Lozano, M. Basora, L. Peidro, et al., “Effectiveness and Safety of Tranexamic Acid Administration during Total Knee Arthroplasty,” Vox Sanguinis, Vol. 95, No. 1, 2008, pp. 39-44. http://dx.doi.org/10.1111/j.1423-0410.2008.01045.x
[10]	N. Tanaka, H. Sakahashi, E. Sato, K. Hirose, T. Ishima and S. Ishii, “Timing of the Administration of Tranexamic Acid for Maximum Reduction in Blood Loss in Arthroplasty of the Knee,” The Journal of Bone & Joint Surgery, Vol. 83, No. 5, 2001, pp. 702-705. http://dx.doi.org/10.1302/0301-620X.83B5.11745
[11]	A. Ahlberg, O. Eriksson and H. Kjellman, “Diffusion of Tranexamic Acid to the Joint,” Acta orthopaedica Scandinavica, Vol. 47, No. 5, 1976, pp. 486-488. http://dx.doi.org/10.3109/17453677608988725
[12]	P. T. Diamond, M. R. Conaway, S. H. Mody and K. Bhirangi, “Influence of Hemoglobin Levels on Inpatient Rehabilitation Outcomes after Total Knee Arthroplasty,” The Journal of Arthroplasty, Vol. 21, No. 5, 2006, pp. 636-641. http://dx.doi.org/10.1016/j.arth.2005.09.006
[13]	A. G. Turpie, M. N. Levine, J. Hirsh, et al., “A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery,” The New England Journal of Medicine, Vol. 315, No. 15, 1986, pp. 925-929. http://dx.doi.org/10.1056/NEJM198610093151503
[14]	S. H. Cohen, G. E. Ehrlich, M. S. Kauffman and C. Cope, “Thrombophlebitis Following Knee Surgery,” The Journal of Bone and Joint Surgery, Vol. 55, No. 1, 1973, pp. 106-112.
[15]	B. I. Eriksson, P. Kalebo, B. A. Anthymyr, H. Wadenvik, L. Tengborn and B. Risberg, “Prevention of Deep-Vein Thrombosis and Pulmonary Embolism after Total Hip Replacement. Comparison of Low-Molecular-Weight Heparin and Unfractionated Heparin,” The Journal of Bone and Joint Surgery, Vol. 73, No. 4, 1991, pp. 484-93.
[16]	P. S. Wells, A. W. Lensing, B. L. Davidson, M. H. Prins and J. Hirsh, “Accuracy of Ultrasound for the Diagnosis of Deep Venous Thrombosis in Asymptomatic Patients after Orthopedic Surgery. A Meta-Analysis,” Annals of Internal Medicine, Vol. 122, No. 1, 1995, pp. 47-53. http://dx.doi.org/10.7326/0003-4819-122-1-199501010-00008
[17]	C. Dollery, “Therapeutic Drugs,” 2nd Edition, Churchill Livingstone, Edinburgh, 1998.
[18]	G. Senthil Kumar, O. A. Von Arx and J. L. Pozo, “Rate of Blood Loss over 48 Hours Following Total Knee Replacement,” The Knee, Vol. 12, No. 4, 2005, pp. 307-309. http://dx.doi.org/10.1016/j.knee.2004.08.008
[19]	L. McGonagle and S. Hakkalamani, “FAC Tranexamic Acid and Re-Infusion Drains in Total Knee Arthroplasty,” European Journal of Orthopaedic Surgery & Traumatology, Vol. 20, No. 7, 2010, pp. 553-555. http://dx.doi.org/10.1007/s00590-010-0625-5
[20]	D. O. Molloy, H. A. Archbold, L. Ogonda, J. McConway, R. K. Wilson and D. E. Beverland, “Comparison of Topical Fibrin Spray and Tranexamic Acid on Blood Loss after Total Knee Replacement: A Prospective, Randomised Controlled Trial,” The Journal of Bone & Joint Surgery, Vol. 89, No. 3, 2007, pp. 306-309. http://dx.doi.org/10.1302/0301-620X.89B3.17565
[21]	M. Sukeik, S. Alshryda, F. S. Haddad and J. M. Mason, “Systematic Review and Meta-Analysis of the Use of Tranexamic Acid in Total Hip Replacement,” The Journal of Bone & Joint Surgery, Vol. 93, No. 1, 2011, pp. 39-46. http://dx.doi.org/10.1302/0301-620X.93B1.24984
[22]	R. Quintavalla, P. Larini, A. Miselli, et al., “Duplex Ultrasound Diagnosis of Symptomatic Proximal Deep Vein Thrombosis of Lower Limbs,” European Journal of Radiology, Vol. 15, No. 1, 1992, pp. 32-36. http://dx.doi.org/10.1016/0720-048X(92)90199-J
[23]	Y. M. R. M. Estrada and S. A. Oldham, “CTPA as the Gold Standard for the Diagnosis of Pulmonary Embolism. International Journal of Computer Assisted Radiology and Surgery, Vol. 6, No. 4, 2010, pp. 557-563. http://dx.doi.org/10.1007/s11548-010-0526-4